A Temperature-Accelerated Molecular Dynamics Study of the Insulin Receptor Kinase

Wednesday, November 10, 2010
Hall 1 (Salt Palace Convention Center)
Harish Vashisth, Chemical Engineering, Drexel University, Philadelphia, PA and Cameron F. Abrams, Drexel University, Philadelphia, PA

Receptor tyrosine kinases are allosteric enzymes that catalyze the phosphorylation of specific tyrosines on protein substrates. The insulin receptor (IR) is a ligand-activated tyrosine kinase, whose biological function and ligand-stimulated catalytic activity depends upon trans-autophosphorylation of three activation loop (A-loop) tyrosines located in each of its cytoplasmic kinase domain (IRKD). The crystal structures of the excised inactive and active IRKD reveal that the A-loop is displaced by ~20 Å on activation. The highly conserved residues Asp1150, Phe1151, and Gly1152 at the N-terminus of the A-loop (the "DFG" motif) collectively "flip" to bury the Phe1151 underneath αC-helix, and simultaneously present Asp1150 for ATP binding. However, the exact mechanism of the conformational change in the A-loop which leads to the "DFG-flip" remains elusive, chiefly due to the unavailability of structural data on intermediate conformations of the A-loop. In this work, we have studied the inactive to active transition of the A-loop at the atomistic level using temperature accelerated molecular dynamics (TAMD). Starting with the inactive A-loop conformation, TAMD (50-ns) generated a target A-loop conformation within ~8 Å (RMSD) of the known active A-loop conformation. A further 20-ns MD-equilibration of this structure in the presence of ATP and phosphotyrosines stabilizes the A-loop conformation to an RMSD of ~4 Å with respect to its active state. Significantly, we also capture the DFG-flip during TAMD, and observe that this flip is facilitated by a transient three-turn helical conformation of the A-loop, the folding of which draws the placement of the side-chains of Phe1151 and Asp1152. Such transient helical conformations of the A-loop can potentially be exploited for the design of novel inhibitors that target a specific DFG conformation, and have been observed in crystal structures of related kinase families.

Extended Abstract: File Not Uploaded